Melinda Gooderham
Queen's University(CA)SKiN Health(CA)Probity Medical Research(CA)Kingston Health Sciences Centre(CA)Trent University(CA)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Autoimmune Bullous Skin Diseases, Allergic Rhinitis and Sensitization
Most-Cited Works
- → Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial(2017)1,211 cited
- → Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis(2017)506 cited
- → Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis(2019)487 cited
- → Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)(2015)472 cited
- → Topical tofacitinib for atopic dermatitis: a phase II a randomized trial(2016)410 cited
- → Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis(2018)409 cited